A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity.

about

A HER2 bispecific antibody can be efficiently expressed in Escherichia coli with potent cytotoxicity.

Item

http://www.wikidata.org/entity/Q55401253

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@en

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@nl

type

Item

label

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@en

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@nl

prefLabel

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@en

A HER2 bispecific antibody can ...... coli with potent cytotoxicity.

@nl

P1476

A HER2 bispecific antibody can ...... coli with potent cytotoxicity

@en

P2093

Bin Dong

http://www.w3.org/2001/XMLSchema#string

Changhua Zhou

http://www.w3.org/2001/XMLSchema#string

Jiayu Liu

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

Limin Lin

http://www.w3.org/2001/XMLSchema#string

Qing Li

http://www.w3.org/2001/XMLSchema#string

Rui Shu

http://www.w3.org/2001/XMLSchema#string

Zhong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Bispecific T-cell engaging antibodies for cancer therapy

Antibody therapy of cancer

Trastuzumab--mechanism of action and use in clinical practice

A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

E. coli expression and purification of Fab antibody fragments.

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.

Secretory and extracellular production of recombinant proteins using Escherichia coli.

Biology of HER2 and its importance in breast cancer.

P304

1259-1266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8698

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963199

http://www.w3.org/2001/XMLSchema#string

P932

6019972

http://www.w3.org/2001/XMLSchema#string